Lighthouse Group* (LGT): Organic growth accelerating (CORP) | ANGLE* (AGL): Liquid biopsy play with early traction (CORP) | Alumasc (ALU): Interims in line, dividend stronger than forecast (BUY) | OptiBiotix* (OPTI): TATA scale up & manufacturing agreement (CORP) | Vipera* (VIP): H1 sales growth and global expansion (CORP) | Mattioli Woods (MTW): Up with events (HOLD)

05 Sep 2017
Morning Note
ANGLE plc (AGL:LON), 2.2 | Alumasc Group plc (ALU:LON), 342 | OptiBiotix Health PLC (OPTI:LON), 10.8

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
ANGLE plc (AGL:LON), 2.2 | Alumasc Group plc (ALU:LON), 342 | OptiBiotix Health PLC (OPTI:LON), 10.8
- Published:
05 Sep 2017 -
Author:
David Buxton | Mark Brewer | Cavendish Research -
Pages:
8 -
Lighthouse Group* (LGT): Organic growth accelerating (CORP) | ANGLE* (AGL): Liquid biopsy play with early traction (CORP) | Alumasc (ALU): Interims in line, dividend stronger than forecast (BUY) | OptiBiotix* (OPTI): TATA scale up & manufacturing agreement (CORP) | Vipera* (VIP): H1 sales growth and global expansion (CORP) | Mattioli Woods (MTW): Up with events (HOLD)